Respiratory Conditions

NHS prescribing intelligence on inhalers, spacers, drugs and other devices used in asthma and COPD

The management of respiratory conditions represents a significant percentage of UK community prescribing. 

With increased NHS focus on the safe and appropriate prescribing of inhaled medicines, GPrX includes a specific respiratory dashboard benchmarking SABA rates at practice level against local and national comparators.

Select an RxIndex below to see the top-line brand market share movement of some of the most commonly-prescribed inhalers. Full breakdown and trends are available with a GPrX login.


Additional resources on prescribing for respiratory conditions

Click below for some of GPrX's content around this therapy area

Further Resources:

Other industry sectors Free useful downloads